AI Chatbot for Osteoarthritis
(CHAT-OA Trial)
Trial Summary
What is the purpose of this trial?
The goal of this clinical trial is to assess the use of a generative artificial intelligence large language model chatbot in improving decision making factors in patients with hip and knee osteoarthritis. The main questions it aims to answer are: Does the use of an artificial intelligence chatbot have an effect on decisional conflict and anxiety related to decision making? Are changes in decisional conflict correlated with changes in patient reported outcomes? Are changes in decisional conflict correlated with health literacy? Participants will interact with an artificial intelligence chatbot prior to their clinic visit with an orthopaedic surgeon, using a structured prompt.
Research Team
Zachary C Lum, DO
Principal Investigator
University of California, Davis
Eligibility Criteria
This trial is for individuals with hip or knee osteoarthritis who are facing decisions about their healthcare. They should be comfortable interacting with an AI chatbot before meeting with an orthopedic surgeon.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Artificial Intelligence Chatbot (AI Technology)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Davis
Lead Sponsor
Rakesh Dixit
University of California, Davis
Chief Executive Officer since 2024
PhD in Biochemistry and Molecular Biology from the University of California, Davis
Suresh Mahabhashyam
University of California, Davis
Chief Medical Officer since 2020
MD from Bangalore Medical College